Siga Technologies (SIGA) Change in Receivables (2010 - 2025)
Siga Technologies' (SIGA) quarterly Change in Receivables came in at -$4.0 million in Q3 2025, down 227.49% on a YoY basis from $3.1 million in Q3 2024, and down 471.61% quarter-over-quarter from -$699108.0 in Q2 2025.
Analysis
Siga Technologies (SIGA) Change in Receivables (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Change in Receivables for 16 consecutive years, with -$4.0 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Change in Receivables fell 227.49% year-over-year to -$4.0 million; the trailing twelve-month figure through Sep 2025 stood at -$9.6 million (down 337.66% YoY), and the FY2024 full-year result was $35178.0, up 100.14% from the prior year.
- Change in Receivables declined to -$4.0 million in Q3 2025 per SIGA's latest filing, from -$699108.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $79.8 million in Q4 2021 and bottomed at -$78.3 million in Q1 2022.
- Historically, Change in Receivables has averaged -$44738.4 across 5 years, with a median of -$699108.0 in 2025.
- The widest YoY moves for Change in Receivables: up 1144.17% in 2022, down 11947.51% in 2022.
- Over 5 years, Change in Receivables stood at $79.8 million in 2021, then tumbled by 111.92% to -$9.5 million in 2022, then soared by 237.42% to $13.1 million in 2023, then plunged by 30.61% to $9.1 million in 2024, then slumped by 144.02% to -$4.0 million in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$4.0 million, -$699108.0, and -$14.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 73.80 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | -1.70 Mn |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -699,108.00 |
| Mar 31, 2025 | -13.98 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | -9.17 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | -6.29 Mn |
| Mar 31, 2023 | -33.09 Mn |
| Dec 31, 2022 | -9.52 Mn |
| Sep 30, 2022 | 35.33 Mn |
| Jun 30, 2022 | 14.26 Mn |
| Mar 31, 2022 | -78.31 Mn |
| Dec 31, 2021 | 79.83 Mn |
| Sep 30, 2021 | -3.38 Mn |
| Jun 30, 2021 | 3.20 Mn |
| Mar 31, 2021 | 660,996.00 |
| Dec 31, 2020 | -37.06 Mn |